Who owns Corbus Pharmaceuticals Holdings, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CRBP from SEC Form 13F filings across 107 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 107 institutions disclosed 13.8M shares of Corbus Pharmaceuticals Holdings, Inc. worth $129.1M — about 70.9% of shares outstanding; the largest disclosed holder is Cormorant Asset Management, LP. Source: SEC Form 13F filings, parsed by EvidInvest.
107
13F holders
$129.1M
value, 2026 filers
70.9%
of shares outstanding (13.8M sh)
26
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of CRBP's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Cormorant Asset Management, LP | 2.3M | $22.0M | 1.1% | 12.1% | 0.0% |
| 2 | ORBIMED ADVISORS LLC | 1.7M | $16.3M | 0.3% | 9% | 0.0% |
| 3 | BlackRock, Inc. | 1.3M | $12.5M | 0.0% | 6.9% | +390.0% |
| 4 | Aberdeen Group plc | 1.3M | $12.4M | 0.0% | 6.8% | 0.0% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 760,940 | $7.1M | 0.0% | 3.9% | +3.7% |
| 6 | Jones Hill Capital LPNEW | 653,572 | $6.1M | 1.3% | 3.4% | new |
| 7 | Prosight Management, LP | 650,000 | $6.1M | 1.1% | 3.3% | -6.8% |
| 8 | Stonepine Capital Management, LLC | 425,000 | $4.0M | 2.2% | 2.2% | +10.8% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 423,374 | $4.0M | 0.0% | 2.2% | +126.4% |
| 10 | ADAR1 Capital Management, LLC | 421,787 | $4.0M | 0.2% | 2.2% | +27.1% |
| 11 | DIADEMA PARTNERS LP | 301,264 | $2.8M | 0.4% | 1.6% | -31.5% |
| 12 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 293,203 | $2.8M | 0.0% | 1.5% | -12.1% |
| 13 | STATE STREET CORP | 254,672 | $2.4M | 0.0% | 1.3% | +269.8% |
| 14 | DIMENSIONAL FUND ADVISORS LP | 190,214 | $1.8M | 0.0% | 1% | +39.2% |
| 15 | Exome Asset Management LLC | 184,914 | $1.7M | 1.1% | 1% | -21.0% |
| 16 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 151,640 | $1.4M | 0.0% | 0.8% | -5.5% |
| 17 | JANE STREET GROUP, LLC | 139,133 | $1.3M | 0.0% | 0.7% | +90.1% |
| 18 | NORTHERN TRUST CORP | 124,906 | $1.2M | 0.0% | 0.6% | +200.9% |
| 19 | VANGUARD FIDUCIARY TRUST CO | 112,397 | $1.1M | 0.0% | 0.6% | +16.8% |
| 20 | VANGUARD PORTFOLIO MANAGEMENT LLC | 111,302 | $1.0M | 0.0% | 0.6% | +356.8% |
| 21 | RENAISSANCE TECHNOLOGIES LLC | 110,822 | $1.0M | 0.0% | 0.6% | -68.1% |
| 22 | DAFNA Capital Management LLCNEW | 107,773 | $1.0M | 0.2% | 0.6% | new |
| 23 | CITADEL ADVISORS LLC | 92,154 | $864,405 | 0.0% | 0.5% | -87.3% |
| 24 | Advisory Services Network, LLC | 89,951 | $843,740 | 0.0% | 0.5% | +642407.1% |
| 25 | MARSHALL WACE, LLP | 79,331 | $744,125 | 0.0% | 0.4% | -45.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.